Current topics in tetanus.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D003422:Critical Care; D003604:Czechoslovakia; D004347:Drug Interactions; D006331:Heart Diseases / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007194:India; D007231:Infant, Newborn; D007278:Injections, Spinal; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use; D010289:Parenteral Nutrition, Total; D011433:Propranolol / Q000627:therapeutic use; D013742:Tetanus / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D013743:Tetanus Antitoxin / Q000008:administration & dosage; D013745:Tetanus Toxoid / Q000627:therapeutic use; D014140:Tracheotomy; D014481:United States; D014611:Vaccination
D000317:Adrenergic alpha-Antagonists; D000925:Anticoagulants; D009125:Muscle Relaxants, Central; D009466:Neuromuscular Blocking Agents; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid; D011433:Propranolol